Molecular Residual Disease in Solid Tumors: A Prospective Study to Collect Clinical Data and Biospecimens to Support Discovery and Development of Cancer Biomarkers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06605404

Title field or adapter rule

{'original_value': 'Molecular Residual Disease in Solid Tumors: A Prospective Study to Collect Clinical Data and Biospecimens to Support Discovery and Development of Cancer Biomarkers', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:25.089197+00:00

Published At

2026-09-24T00:00:00+00:00

Record Updated At

2026-09-24

Source Retrieved At

2026-10-31T22:17:54.613222+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Muscle Invasive Bladder Urothelial Carcinoma", "Esophageal Cancer", "Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma", "Melanoma (Skin Cancer)", "NSCLC (Non-small Cell Lung Cancer)", "Pancreatic (Exocrine Only)", "Mix of Solid Tumors (MOST)"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-09-24", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT06605404"

protocolSection.identificationModule.officialTitle

"Molecular Residual Disease in Solid Tumors: A Prospective Study to Collect Clinical Data and Biospecimens to Support Discovery and Development of Cancer Biomarkers"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

null

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Muscle Invasive Bladder Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
• Esophageal Cancer (protocolSection.conditionsModule.conditions)
• Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma (protocolSection.conditionsModule.conditions)
• Melanoma (Skin Cancer) (protocolSection.conditionsModule.conditions)
• NSCLC (Non-small Cell Lung Cancer) (protocolSection.conditionsModule.conditions)
• Pancreatic (Exocrine Only) (protocolSection.conditionsModule.conditions)
• Mix of Solid Tumors (MOST) (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Esophageal', 'Gastric and Gastroesophageal Junction (GEJ)', 'Melanoma', 'Mix of Solid Tumors (MOST)', 'Muscle Invasive Urothelial Carcinoma of the Bladder (MIBC)', 'Non-small cell lung (NSCLC)', 'Pancreatic (exocrine only)'], 'description': 'routine standard of care', 'name': 'blood and tissue samples', 'type': 'DIAGNOSTIC_TEST'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Esophageal', 'Gastric and Gastroesophageal Junction (GEJ)', 'Melanoma', 'Mix of Solid Tumors (MOST)', 'Muscle Invasive Urothelial Carcinoma of the Bladder (MIBC)', 'Non-small cell lung (NSCLC)', 'Pancreatic (exocrine only)'], 'description': 'Routine standard of care', 'name': 'blood and tissue samples', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.